Clinical Trials Browser

Phase 1 × Sarcoma × Everolimus × Clear all

NCT00187174 2015-03-04

Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors

Phase 1 Completed

Brain Neoplasms, Neoplasms, Recurrence, Rhabdomyosarcoma, Sarcoma

NCT00927966 2013-11-14

RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms

Phase 1 Completed

Sarcoma